The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting ...

Microangiopathic hemolytic anemia (MAHA) occurs when turbulence in the blood destroys red blood cells. This leads to symptoms such as tiredness and shortness of breath. Certain treatments are ...